2021•Journal of the American Academy of DermatologyRequires access

26670 The contribution of itch and skin severity improvements to the Dermatology Life Quality Index in patients with atopic dermatitis in a baricitinib phase 3 study, BREEZE-AD5

Gil Yosipovitch, Kim Papp, Seth Forman, George Han, Jill Waibel, María José Rueda, Luna Sun, Yun-Fei Chen, Orin M. Goldblum, Evangeline Pierce, Jonathan I. Silverberg

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Dermatology Life Quality Index, Eczema Area and Severity Index, Atopic dermatitis, Medicine, Post-hoc analysis, Dermatology, Placebo, Quality of life (healthcare)